These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38071891)

  • 1. Novel partial reduction of the humanized anti-cocaine mAb h2E2 for selective cysteine labeling.
    Kirley TL; Norman AB
    Biochem Biophys Res Commun; 2024 Jan; 692():149362. PubMed ID: 38071891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and optimization of fluorescein isothiocyanate labeling of humanized h2E2 anti-cocaine mAb.
    Kirley TL; Norman AB
    Biochem Biophys Rep; 2023 Sep; 35():101520. PubMed ID: 37554426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand binding to a humanized anti-cocaine mAb detected by non-reducing SDS-PAGE.
    Kirley TL; Norman AB
    Biochem Biophys Rep; 2020 Sep; 23():100795. PubMed ID: 32817883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel differential scanning fluorimetry analysis of a humanized anti-cocaine mAb and its ligand binding characteristics.
    Kirley TL; Norman AB; Wetzel HN
    J Immunol Methods; 2020 Jan; 476():112676. PubMed ID: 31634480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective disulfide reduction for labeling and enhancement of Fab antibody fragments.
    Kirley TL; Greis KD; Norman AB
    Biochem Biophys Res Commun; 2016 Nov; 480(4):752-757. PubMed ID: 27983990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased solubility and increased adsorptivity of a biotinylated humanized anti-cocaine mAb.
    Kirley TL; Norman AB
    Anal Biochem; 2025 Jan; 696():115690. PubMed ID: 39426697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment.
    Kirley TL; Norman AB
    Hum Vaccin Immunother; 2015; 11(2):458-67. PubMed ID: 25692880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical evaluation of fluorescent dyes to evaluate the stability and ligand binding properties of an anti-cocaine mAb, h2E2.
    Kirley TL; Norman AB
    J Immunol Methods; 2022 Sep; 508():113323. PubMed ID: 35843267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine nitration of a humanized anti-cocaine mAb differentially affects ligand binding of cocaine and its metabolites.
    Kirley TL; Greis KD; Norman AB
    Biochem Biophys Rep; 2022 Jul; 30():101278. PubMed ID: 35600901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isothermal titration calorimetry determination of thermodynamics of binding of cocaine and its metabolites to humanized h2E2 anti-cocaine mAb.
    Kirley TL; Norman AB
    Biochem Biophys Rep; 2022 Dec; 32():101354. PubMed ID: 36186732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand binding to a humanized anti-cocaine mAb measured by dye absorption spectroscopy.
    Kirley TL; Norman AB
    Biochem Biophys Res Commun; 2021 Jan; 535():93-98. PubMed ID: 33348081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-domain unfolding of the Fab fragment of a humanized anti-cocaine mAb characterized by non-reducing SDS-PAGE.
    Kirley TL; Norman AB
    Biochem Biophys Res Commun; 2020 Dec; 533(3):580-585. PubMed ID: 32988582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domain unfolding of monoclonal antibody fragments revealed by non-reducing SDS-PAGE.
    Kirley TL; Greis KD; Norman AB
    Biochem Biophys Rep; 2018 Dec; 16():138-144. PubMed ID: 30417132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of specific tryptophan residues inhibits high-affinity binding of cocaine and its metabolites to a humanized anticocaine mAb.
    Kirley TL; Norman AB; Greis KD
    J Biol Chem; 2022 Mar; 298(3):101689. PubMed ID: 35143837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reformulation and Thermal Stability of a Therapeutic Anti-Cocaine mAb.
    Kirley TL; Norman AB
    J Pharm Sci; 2023 Jun; 112(6):1595-1602. PubMed ID: 37011728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine binding to the Fab fragment of a humanized anti-cocaine mAb quantitated by dye absorption and fluorescence spectroscopy.
    Kirley TL; Norman AB
    J Immunol Methods; 2021 Sep; 496():113103. PubMed ID: 34298065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mathematical model of a recombinant humanized anti-cocaine monoclonal antibody's effects on cocaine pharmacokinetics in mice.
    Wetzel HN; Zhang T; Norman AB
    Life Sci; 2017 Sep; 184():81-86. PubMed ID: 28694087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and quantification of free sulfhydryls in monoclonal antibodies using maleimide labeling and mass spectrometry.
    Robotham AC; Kelly JF
    MAbs; 2019; 11(4):757-766. PubMed ID: 30894096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates.
    Liu-Shin L; Fung A; Malhotra A; Ratnaswamy G
    MAbs; 2018; 10(4):583-595. PubMed ID: 29436897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant humanized anti-cocaine monoclonal antibody inhibits the distribution of cocaine to the brain in rats.
    Norman AB; Gooden FC; Tabet MR; Ball WJ
    Drug Metab Dispos; 2014 Jul; 42(7):1125-31. PubMed ID: 24733787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.